Big Data and AI Can Guide Cannabis Medicine
August 30, 2021
Robin Lefferts August 30th, 2021 App, Exclusive, News, Top Story In order for cannabis medicine to make the big leap to mainstream acceptance, a few things likely have to take place. Doctors, not just cannabis providers, need to become more comfortable discussing and prescribing the plant. Regulations need to... Read more
Ryan Allway August 20th, 2021 App, Exclusive, News, Top Story Nature is the lifeblood of the health and wellness industry. In fact, rainforest plants account for the raw material to produce a quarter of Western pharmaceuticals, including more than 120 different drugs. The challenge is understanding natural compounds and... Read more
Ryan Allway August 17th, 2021 App, Psychedelics, Top Story Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Silo Pharma Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the therapeutic potential of psychedelics, recently announced that the U.S.... Read more
New CBD Trials Point the Way for Enveric, MagicMed
CBD July 30, 2021
Ryan Allway July 30th, 2021 Psychedelics, Top Story As the cannabis industry strives to gain widespread acceptance in the mainstream, scientific studies into the potential benefits of the plant and its active ingredients play a key role in reaching that goal. There are currently very few approved pharmaceutical drug... Read more
Silo Pharma Takes Next Step in Bringing Homing Peptide Tech to $30+ Billion RA Market
Uncategorized July 23, 2021
Ryan Allway July 23rd, 2021 Psychedelics, Top Story, Uncategorized Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease that causes painful swelling in joints in the hands, wrists, and knees. While medications can slow the disease and prevent joint deformity, there is no cure for the condition, and... Read more
Rising Cannabis Extractor Going Public Today
July 15, 2021
Robin Lefferts July 15th, 2021 App, Exclusive, News, Top Story In the Canadian cannabis market, Cannabis 3.0 is finally starting to realize the sales potential many investors imagined back in 2019. That is when Canada legalized cannabis-derived products like oils, extracts, and edibles, and the thought was these new... Read more
Robin Lefferts June 21st, 2021 App, Exclusive, News, Top Story Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts.... Read more
3 Ways to Invest in AI & Machine Learning
June 16, 2021
Ryan Allway June 16th, 2021 Psychedelics, Top Story Artificial intelligence has revolutionized computer science over the past decade. In fact, in a new paper submitted to the peer-reviewed Artificial Intelligence journal, scientists at the UK-based AI lab DeepMind argue that generalized intelligence will emerge from the reinforcement learning and... Read more
Ovation Science’s Proven Science, IP, and Royalty Model Protects Investors and the Company
CBD June 9, 2021
Ryan Allway June 9th, 2021 App, Exclusive, News, Top Story If a company has developed very effective, transformative technology, it takes an investment into research and development and time. It also pays to protect it from copycats and pirates with patents. And if the company’s specialty is science and... Read more
Robin Lefferts June 7th, 2021 App, Exclusive, News, Top Story As the legal cannabis industry matures and expands, the goal of many companies is (and should be) to reach people who might not historically be cannabis consumers. According to a 2020 Gallup poll, about 12% of US adults say... Read more
